Eos Advisory is a venture capital firm that focuses on early-stage investments in science and technology companies. Their strategy targets businesses addressing significant societal and environmental challenges, including disease diagnostics, food and water security, energy security, climate change, pollution, and sustainable industrial processes.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals). Average disclosed round size is $5.6M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Bioliberty | Series A | $8.2M | Mar 2026 |
 EnsiliTech | Seed | $5.2M | Aug 2025 |
 Naturbeads | Series A | $7.8M | Nov 2024 |
| CChromacity | Unknown | $1.3M | Jul 2024 |
Top Co-Investors
Scottish Enterprise1 shared
Innovate UK1 shared
Calculus Capital1 shared
Empirical Ventures1 shared
CDP Venture Capital1 shared
Last updated: 10 April 2026